ATOMIC Trial ASCO 2025: Key Results RevealedOn June 1, 2025, the ASCO Annual Meeting in Chicago presented the ATOMIC trial…
Browsing: Atezolizumab
We recognize that That combination also made them immunogenic. And so there was always recognition. Over time we came to appreciate that when you see the immune system in there where there’s immune lymphocytes in the tumor, those tumors, those patients seem to do better even in the absence of drug therapy and with drug therapy they do better still.
J. Randolph Hecht, MD from UCLA Health is conducting a phase 3 clinical trial called STELLAR-303 to evaluate the efficacy…